RU2011152518A - Применение композиции для лечения мукозита - Google Patents
Применение композиции для лечения мукозита Download PDFInfo
- Publication number
- RU2011152518A RU2011152518A RU2011152518/15A RU2011152518A RU2011152518A RU 2011152518 A RU2011152518 A RU 2011152518A RU 2011152518/15 A RU2011152518/15 A RU 2011152518/15A RU 2011152518 A RU2011152518 A RU 2011152518A RU 2011152518 A RU2011152518 A RU 2011152518A
- Authority
- RU
- Russia
- Prior art keywords
- composition
- specified
- range
- chitosan
- mucositis
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract 47
- 238000011282 treatment Methods 0.000 title claims abstract 6
- 229920001661 Chitosan Polymers 0.000 claims abstract 19
- 150000004676 glycans Chemical class 0.000 claims abstract 17
- 229920001282 polysaccharide Polymers 0.000 claims abstract 17
- 239000005017 polysaccharide Substances 0.000 claims abstract 17
- 206010028116 Mucosal inflammation Diseases 0.000 claims abstract 15
- 201000010927 Mucositis Diseases 0.000 claims abstract 15
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 claims abstract 7
- 229920000669 heparin Polymers 0.000 claims abstract 7
- 229960002897 heparin Drugs 0.000 claims abstract 7
- 229920002971 Heparan sulfate Polymers 0.000 claims abstract 4
- 241000124008 Mammalia Species 0.000 claims abstract 4
- 229960000633 dextran sulfate Drugs 0.000 claims abstract 4
- 230000006196 deacetylation Effects 0.000 claims abstract 3
- 238000003381 deacetylation reaction Methods 0.000 claims abstract 3
- 239000002518 antifoaming agent Substances 0.000 claims abstract 2
- 239000004599 antimicrobial Substances 0.000 claims abstract 2
- 238000000034 method Methods 0.000 claims 6
- 239000008194 pharmaceutical composition Substances 0.000 claims 4
- 238000002512 chemotherapy Methods 0.000 claims 2
- 210000000214 mouth Anatomy 0.000 claims 2
- 238000001959 radiotherapy Methods 0.000 claims 2
- 238000009168 stem cell therapy Methods 0.000 claims 2
- 238000009580 stem-cell therapy Methods 0.000 claims 2
- 206010028980 Neoplasm Diseases 0.000 claims 1
- 201000011510 cancer Diseases 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 210000001035 gastrointestinal tract Anatomy 0.000 claims 1
- 239000007788 liquid Substances 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 239000002324 mouth wash Substances 0.000 claims 1
- 229940051866 mouthwash Drugs 0.000 claims 1
- 239000000725 suspension Substances 0.000 claims 1
- 238000011200 topical administration Methods 0.000 claims 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/716—Glucans
- A61K31/722—Chitin, chitosan
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/716—Glucans
- A61K31/721—Dextrans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
- A61K31/727—Heparin; Heparan
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/737—Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Dermatology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dispersion Chemistry (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE0950441-6 | 2009-06-10 | ||
| SE0950441 | 2009-06-10 | ||
| PCT/SE2010/050650 WO2010144044A1 (en) | 2009-06-10 | 2010-06-10 | Use of a composition for the treatment of mucositis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| RU2011152518A true RU2011152518A (ru) | 2013-07-20 |
Family
ID=43309105
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2011152518/15A RU2011152518A (ru) | 2009-06-10 | 2010-06-10 | Применение композиции для лечения мукозита |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US8906883B2 (https=) |
| EP (1) | EP2440216A4 (https=) |
| JP (1) | JP2012529506A (https=) |
| CN (1) | CN102458419A (https=) |
| AU (1) | AU2010259284A1 (https=) |
| BR (1) | BRPI1009741A2 (https=) |
| CA (1) | CA2763092A1 (https=) |
| RU (1) | RU2011152518A (https=) |
| WO (1) | WO2010144044A1 (https=) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2795520C (en) | 2010-04-06 | 2018-03-06 | Synedgen Inc. | Methods and compositions for treating wounds utilizing chitosan compounds |
| WO2014047506A1 (en) | 2012-09-20 | 2014-03-27 | Synedgen, Inc. | Methods for treatment or prevention of damage resulting from radiation, trauma or shock |
| US20160193244A1 (en) * | 2013-08-13 | 2016-07-07 | Seikagaku Corporation | Drug containing cationized chitosan |
| SG11201603081WA (en) * | 2013-10-22 | 2016-05-30 | Cantex Pharmaceuticals Inc | Methods of treating and preventing radiation damage |
| US20180228832A1 (en) * | 2015-08-18 | 2018-08-16 | Pharma Seeds Create, Llc | Stomatological composition containing nsaid or heparin compound |
| EP3787593A1 (en) * | 2018-05-04 | 2021-03-10 | Bonoss Medical Aktiebolag | A composition for reduction of scar formation |
| WO2019236453A1 (en) | 2018-06-03 | 2019-12-12 | Glycomira Therapeutics, Inc. | Methods for preventing a serious health consequence and/or tissue damage after exposure to ionizing radiation and /or chemotherapy |
| WO2021216494A1 (en) * | 2020-04-24 | 2021-10-28 | Intact Therapeutics, Inc. | Compositions and methods for treatment of gastrointestinal bleeding |
| EP3981505B1 (en) * | 2020-10-12 | 2024-11-27 | Gambro Lundia AB | Membrane with immobilized anticoagulant and process for producing same |
| SE545090C2 (en) * | 2021-03-17 | 2023-03-28 | Labrida As | A hydrogel comprising chitosan for use in prevention and treatment of periodontal and peri-implant disease |
| EP4401784A4 (en) * | 2021-09-17 | 2025-09-10 | Shawn Walker | USE OF CHITOSAN COMPLEXES OR COMPOSITIONS TO REDUCE THE INFILTRATION OF ENVIRONMENTAL FACTORS INTO THE BRAIN |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE9402531L (sv) * | 1994-07-19 | 1996-01-20 | Medicarb Ab | Sårläkningsmedel |
| SE9402529D0 (sv) | 1994-07-19 | 1994-07-19 | Astra Ab | Anti-adherensmedel |
| SE507028C2 (sv) | 1996-08-06 | 1998-03-16 | Medicarb Ab | Ny medicinsk användning |
| US6989156B2 (en) | 2001-04-23 | 2006-01-24 | Nucryst Pharmaceuticals Corp. | Therapeutic treatments using the direct application of antimicrobial metal compositions |
| DK1363600T3 (da) | 2001-02-15 | 2009-01-26 | Access Pharma Inc | Flydende formuleringer til forebyggelse og behandling af mucosale sygdomme og lidelser |
| EP1539192A1 (en) * | 2002-04-24 | 2005-06-15 | Medicarb AB | Composition and kit for the treatment of inflammatory bowel diseases |
| CA2501614A1 (en) * | 2002-10-07 | 2004-04-22 | Orapharma, Inc. | Mucoadhesive tetracycline formulations |
| CA2581076A1 (en) * | 2004-09-14 | 2006-03-23 | Molecular Therapeutics, Inc. | D-methionine formulation with improved biopharmaceutical properties |
| EP1838335A1 (en) * | 2005-01-19 | 2007-10-03 | Bonoss Medical AB | Growth factor composition |
| DE102006024831B4 (de) | 2006-05-24 | 2008-03-27 | Heraeus Quarzglas Gmbh & Co. Kg | Verfahren zur Herstellung eines Halbzeugs aus synthetischem Quarzglas |
| WO2008060764A2 (en) | 2006-10-05 | 2008-05-22 | Drugtech Corporation | Topical therapies for oral mucositis and other conditions |
-
2010
- 2010-06-10 US US13/376,947 patent/US8906883B2/en not_active Expired - Fee Related
- 2010-06-10 RU RU2011152518/15A patent/RU2011152518A/ru not_active Application Discontinuation
- 2010-06-10 CN CN2010800254173A patent/CN102458419A/zh active Pending
- 2010-06-10 WO PCT/SE2010/050650 patent/WO2010144044A1/en not_active Ceased
- 2010-06-10 EP EP10786461.3A patent/EP2440216A4/en not_active Withdrawn
- 2010-06-10 JP JP2012514923A patent/JP2012529506A/ja active Pending
- 2010-06-10 AU AU2010259284A patent/AU2010259284A1/en not_active Abandoned
- 2010-06-10 CA CA2763092A patent/CA2763092A1/en not_active Abandoned
- 2010-06-10 BR BRPI1009741A patent/BRPI1009741A2/pt not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| AU2010259284A1 (en) | 2011-12-15 |
| BRPI1009741A2 (pt) | 2016-03-15 |
| US8906883B2 (en) | 2014-12-09 |
| WO2010144044A1 (en) | 2010-12-16 |
| CA2763092A1 (en) | 2010-12-16 |
| US20120077773A1 (en) | 2012-03-29 |
| EP2440216A1 (en) | 2012-04-18 |
| CN102458419A (zh) | 2012-05-16 |
| EP2440216A4 (en) | 2013-09-11 |
| JP2012529506A (ja) | 2012-11-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2011152518A (ru) | Применение композиции для лечения мукозита | |
| CN102114031B (zh) | 使用于炎症性肠疾病治疗和预防的透明质酸混合物 | |
| RU2010117016A (ru) | Хитозановая композиция | |
| ES2739227T3 (es) | Partículas de membrana de cáscara de huevo micronizada y el uso de las mismas para favorecer la cicatrización de heridas | |
| ES2887581T3 (es) | Formulaciones farmacéuticas que comprenden sulfato de condroitina y derivados de ácido hialurónico | |
| JP2011522879A5 (https=) | ||
| FI3076983T4 (fi) | Ionisia nestemäisiä koostumuksia | |
| JPH04500798A (ja) | 硫酸化糖類の用途 | |
| RU2013125021A (ru) | Местные композиции для сохранения или восстановления целостности слизистых оболочек | |
| JP2012529506A5 (https=) | ||
| ATE511847T1 (de) | Pharmazeutische zubereitung für die behandlung entzündlicher erkrankungen des urogenitaltraktes | |
| AU2010212350B2 (en) | Mixture of hyaluronic acid for treating and preventing inflammatory bowel disease | |
| JP2011037849A (ja) | 消化性潰瘍及び十二指腸潰瘍の治療及び予防に使用されるヒアルロン酸混合物 | |
| He et al. | Research Progress of Multifunctional Hydrogels in Promoting Wound Healing of Diabetes | |
| CN105982912A (zh) | 一种包含透明质酸钠和硫酸软骨素的药物组合物 | |
| Wang et al. | Exudate-triggered bio-based polyurethane hydrogel dressing containing herbal active ingredients for scald wounds healing | |
| CN103655601B (zh) | 一种用于膀胱灌洗的组合物 | |
| SI2874614T1 (en) | Water-soluble film which has a healing effect | |
| JP2006274245A (ja) | 硫酸化セルロース及びその塩から選ばれた化合物並びに皮膚炎治療剤 | |
| CA2779937C (en) | Pharmaceutical composition for the treatment of bladder disorders | |
| RU2018125252A (ru) | Синергическая комбинация пирролидонкарбоновой кислоты и/или ее солей и гиалуроновой кислоты и/или ее солей для применения в лечении и/или профилактике сухости и раздражения слизистых оболочек, и связанные фармацевтические композиции | |
| JP6725108B2 (ja) | ユニチオール及びジメチルスルホキシドを含む消毒組成物、その組成物の使用並びにそれを使用した創傷治療方法 | |
| JP5572110B2 (ja) | 粘膜の疾患および障害の予防および処置のための液体製剤 | |
| RU2013102263A (ru) | Гелевые лекарственные формы для местного применения производных 1-аминоалкилциклогексана | |
| CN105030656A (zh) | 用于非细菌性膀胱炎治疗的透明质酸钠灌洗液 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA94 | Acknowledgement of application withdrawn (non-payment of fees) |
Effective date: 20150716 |